ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA
Clinical trials for ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA explained in plain language.
Never miss a new study
Get alerted when new ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA trials appear
Sign up with your email to follow new studies for ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare heart disease: trial tests drug to halt damage
Disease control Recruiting nowThis study is testing whether a medication called spironolactone can slow the progression of a rare heart muscle disease called ARVD. It will involve 120 patients in France who will take either the drug or a placebo for three years. The goal is to see if the drug can reduce heart…
Matched conditions: ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Apr 01, 2026 23:11 UTC
-
Brazil launches national hunt for genetic causes of heart disease
Knowledge-focused Recruiting nowThis study aims to create a national registry of Brazilian patients with inherited heart conditions to better understand their genetic causes. Researchers will collect health information and DNA samples from 600 participants during their regular doctor visits. The goal is to iden…
Matched conditions: ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA
Sponsor: Hospital do Coracao • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC